Dr. Annemarie Shepherd, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Malignant Pleural Mesothelioma
Studies Mesothelioma
4 reported clinical trials
9 drugs studied
Area of expertise
1Malignant Pleural Mesothelioma
Stage III
Stage I
Stage II
2Mesothelioma
Stage III
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Annemarie Shepherd, MD is currently running
IMPRINT Radiation Therapy
for Thymic Cancer
The researchers are doing this study to find out whether hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) is a safe treatment that causes few or mild side effects in people with pleural metastases from thymic malignancies. The researchers will also look at whether hemithoracic IMPRINT is effective against participants' cancer.
Recruiting1 award Phase 211 criteria
Pembrolizumab + Radiation
for Mesothelioma
The purpose of this study is to find out whether IMPRINT in combination with pembrolizumab is a safe treatment for people with malignant pleural mesothelioma (MPM).The highest dose of IMPRINT that causes few or mild side effects when given in combination with pembrolizumab will be found. Once the highest safe dose of IMPRINT is found, it will be tested in combination with pembrolizumab in future participants to see whether the combination may be an effective treatment for MPM.
Recruiting1 award Phase 1
More about Annemarie Shepherd, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Annemarie Shepherd, MD has experience with
- IMPRINT
- Pembrolizumab
- Intensity-Modulated Pleural Radiation Therapy (IMPRINT)
- Cyclical Hypofractionated Palliative Radiation (Quad Shot)
- Carboplatin
- Cisplatin
Breakdown of trials Annemarie Shepherd, MD has run
Malignant Pleural Mesothelioma
Mesothelioma
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Annemarie Shepherd, MD specialize in?
Annemarie Shepherd, MD focuses on Malignant Pleural Mesothelioma and Mesothelioma. In particular, much of their work with Malignant Pleural Mesothelioma has involved Stage III patients, or patients who are Stage I.
Is Annemarie Shepherd, MD currently recruiting for clinical trials?
Yes, Annemarie Shepherd, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Annemarie Shepherd, MD has studied deeply?
Yes, Annemarie Shepherd, MD has studied treatments such as IMPRINT, Pembrolizumab, Intensity-Modulated Pleural Radiation Therapy (IMPRINT).
What is the best way to schedule an appointment with Annemarie Shepherd, MD?
Apply for one of the trials that Annemarie Shepherd, MD is conducting.
What is the office address of Annemarie Shepherd, MD?
The office of Annemarie Shepherd, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.